Associate Director, AI Applications
AstraZeneca1 day ago
Barcelona, SpainStaff+
Responsibilities
- Build agentic AI-driven solutions for scientific research problems.
- Develop, test, and support agentic AI tools for genomics, computational pathology, clinical trials, and related oncology applications.
- Automate complex data analysis processes.
- Introduce leading AI technologies to cancer research.
- Develop, evaluate, and deploy machine learning models through production pipelines.
- Collaborate with clinical and scientific subject-matter experts.
Requirements
- Relevant graduate degree in computer science, engineering, physical sciences, or a related quantitative field.
- Extensive applied experience in data science, machine learning, AI engineering, or a relevant field.
- Hands-on experience building agentic AI systems.
- Strong Python or R programming skills.
- Strong experience with Unix/Linux and SQL databases, plus experience with AWS or Azure cloud computing.
- Strong experience with data science best practices and production ML deployment, including model development, rigorous evaluation, and deployment to production pipelines such as Databricks.
- Strong domain knowledge in clinical oncology, including collaboration with clinical and scientific SMEs and familiarity with clinical trial design and clinical vocabularies.
- Desirable experience with Pydantic-AI, LangChain, retrieval-augmented generation, vector databases, and large language or foundation models.
- Experience with at least one compiled language such as C, Java, Go, or Rust.
Benefits
- In-office role based in Barcelona, Spain, requiring a minimum of three days per week on-site.
- Remote or travel flexibility is not available.
About AstraZeneca
AstraZeneca is a global biopharmaceutical company that discovers, develops, manufactures, and commercializes prescription medicines for patients and healthcare systems. Its portfolio spans oncology, cardiovascular, renal and metabolism, respiratory and immunology, and rare diseases (expanded by the 2021 acquisition of Alexion). Founded in 1999 and headquartered in Cambridge, UK, it is a public company listed on the London Stock Exchange and Nasdaq, generating revenue primarily from drug sales and partnerships.